LUX Infusion Enhances Hemophilia Treatment Accessibility with Qfitlia Introduction

LUX Infusion Expands Hemophilia Care through Qfitlia

LUX Infusion, a clinician-led infusion service network based in the U.S., has announced the launch of Qfitlia (fitusiran), significantly enhancing access and support for individuals diagnosed with hemophilia A or B. With this new subcutaneous treatment, patients aged 12 and older can receive crucial support for routine bleed prevention without facing access barriers.

Commitment to Patients and Care

Ted Kramm, CEO of LUX Infusion, emphasized the company's enduring dedication to the bleeding disorder community. He stated, "Our mission is to make care both easier to access and navigate. Integrating Qfitlia into our services allows us to support patients in managing their condition with a unique treatment option accompanied by personalized assistance."

The program designed for individuals with bleeding disorders goes beyond treatment provision. Patients transitioning to LUX Infusion or starting Qfitlia receive ongoing support throughout their treatment journey. A dedicated team assists them in overcoming initial treatment barriers and continues to offer day-to-day guidance. Each patient is paired with a single point of contact for a more personalized experience, ensuring they have direct access to expertise related to their specific bleeding disorder. With 24/7 on-call guidance, patients can feel secure in their treatment approach.

Accessing Qfitlia

Starting today, Qfitlia is available to patients and healthcare providers through LUX Infusion. Interested patients are encouraged to fill out a form online to begin the process. This initiative aligns with LUX Infusion's promise to deliver coordinated care tailored to the specific needs of patients reliant on complex infusion therapies.

About LUX Infusion

Founded on principles of clinical expertise and high-quality patient experiences, LUX Infusion serves a growing national network of patients, providers, payors, and manufacturers. The company focuses not just on delivering treatments but ensuring that patients receive comprehensive support, from their initial entry into the system to managing ongoing care.

With Qfitlia, LUX Infusion is set to make notable strides in the treatment landscape for hemophilia, aiming to eradicate barriers and improve quality of life for individuals living with these challenging conditions.

To learn more about LUX Infusion and how to access Qfitlia, visit luxinfusion.com. Follow LUX Infusion on social media platforms to stay updated on their latest initiatives and offerings.